Home/Filings/4/0000899243-21-006166
4//SEC Filing

Wadhwa Manish 4

Accession 0000899243-21-006166

CIK 0001574774other

Filed

Feb 10, 7:00 PM ET

Accepted

Feb 11, 9:44 PM ET

Size

11.0 KB

Accession

0000899243-21-006166

Insider Transaction Report

Form 4
Period: 2021-02-09
Wadhwa Manish
SVP & CMO
Transactions
  • Disposition to Issuer

    Common Stock

    2021-02-09$72.00/sh3,616$260,3520 total
  • Disposition to Issuer

    Stock Options (Right to Buy)

    2021-02-09$18.78/sh4,176$78,4250 total
    Exercise: $53.22Exp: 2030-02-17Common Stock (4,176 underlying)
  • Disposition to Issuer

    Performance Stock Units

    2021-02-09$72.00/sh1,754$126,2880 total
    Exercise: $0.00Common Stock (1,754 underlying)
Footnotes (4)
  • [F1]Per the terms of the Agreement and Plan of Merger, dated as of December 18, 2020, among the Company, Philips Holding USA Inc., a Delaware corporation, and Davies Merger Sub, Inc., a Delaware corporation (the "Merger Agreement") and the Offer (as defined in the Merger Agreement), each share of Company common stock was validly tendered for $72.00 per share in cash, without interest and less any applicable withholding taxes.
  • [F2]Includes 1,754 restricted stock units that, pursuant to the Merger Agreement, were cancelled at the Effective Time of the Merger (both as defined in the Merger Agreement) and converted into the right to receive $72.00 per share in cash, less any applicable withholding taxes.
  • [F3]Per the terms of the Merger Agreement, each stock option that was outstanding and unexercised as of the Effective Time (as defined in the Merger Agreement), whether or not vested, was cancelled and converted into the right to receive cash in an amount equal to the product of (i) the total number of shares of Company common stock subject to such stock option immediately prior to the Effective Time, and (ii) the excess, if any, of the Offer Price over the exercise price per share of such stock option, less applicable withholding taxes.
  • [F4]Per the terms of the Merger Agreement, each performance stock unit ("PSU") that was outstanding as of the Effective Time (as defined in the Merger Agreement), whether or not vested, was cancelled and converted into the right to receive cash equal to the product of (i) the total number of shares of Company common stock subject to such PSU that would have vested if the applicable performance period ended immediately prior to the Effective Time (assuming that any applicable performance conditions were deemed to be achieved at the target performance level), multiplied by (ii) the Offer Price, less applicable withholding taxes.

Issuer

BIOTELEMETRY, INC.

CIK 0001574774

Entity typeother

Related Parties

1
  • filerCIK 0001798936

Filing Metadata

Form type
4
Filed
Feb 10, 7:00 PM ET
Accepted
Feb 11, 9:44 PM ET
Size
11.0 KB